New Options On Cortex Driving Abnormal Pricing? (COR)

Cortex Pharmaceuticals (COR) has had an amazing run since I first wrote about them. Until today [Weds.], when they are tanking [ed. note: COR recovered significantly in the afternoon]. The question is whether the run is over or not. The news is that their products have seen some promising results, and in the absence of any other news that I can find indicating a change to that, it seems that the advent of new options is driving abnormal pricing behavior.

So the price drop on huge volume is probably technical, and fundamentals will take over again after a few days. We're holding.

[Disclosure: As of writing, author is long COR]

COR 1-yr chart: